# Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders

> **NCT02081027** · EARLY_PHASE1 · COMPLETED · sponsor: **Children's Hospital Medical Center, Cincinnati** · enrollment: 8 (actual)

## Conditions studied

- Autism Spectrum Disorders

## Interventions

- **DRUG:** Riluzole
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT02081027
- **Lead sponsor:** Children's Hospital Medical Center, Cincinnati
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-09-19
- **Primary completion:** 2015-04
- **Final completion:** 2015-05
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2021-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02081027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02081027, "Pilot Study of Riluzole for Drug-Refractory Irritability in Autism Spectrum Disorders". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02081027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*